Affiliation:
1. Meshalkin National Medical Research Center, Ministry of Healthcare of Russia
Abstract
Hypertrophic cardiomyopathy (HCM) defined by wall thickness ≥ 15 mm in one or more left ventricular myocardium segments, according to the results of any imaging technique that is not explained solely due to increased pressure load. For decades, echocardiography has been the first-line method in the diagnosis of HCM. This is due to its availability, low cost, and informative content. However, due to the high spatial resolution and volumetric nature of image acquisition, magnetic resonance imaging (MRI) has advantages over other diagnostic techniques. Currently, cardiac MRI is becoming the method of choice in diagnostics and management in patients with HCM. This article presents the possibilities of MR imaging in patients with HCM and demonstrates the typical phenotypes and some morphological characteristics of HCM according to our research protocols conducted on a MR scanner with a 1,5 T magnetic field strength. In addition, the article shows the clinical significance of MRI for the management of patients with HCM.
Publisher
Central Research Institute of Radiation Diagnostics
Reference20 articles.
1. Afanas'ev A. V., Bogachev-Prokof'ev A. V., Zheleznev S. I. et al. Septal myectomy with subvalvular apparatus intervention in patients with hypertrophic obstructive cardiomyopathy: immediate results // Sibirskij med. zhurnal. 2018. No. 3. Р. 71– 77 (in Russian).
2. Mershina E. A., Sinicyn V. E., Larina O. M. Cardiac magnetic resonance in hypertrophic and sudden cardiac risk stratification. Klin. i jeksperim. hir. zhurnal im. akad. B. V. Petrovskogo. 2019. V. 7. No. 3. Р. 70–78 (in Russian).
3. Shajahmetova S. V., Sinicyn V. E., Afanas'ev A. V. Cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: diagnostic and prognostic value. Ros. kardiol. zhurnal. 2019. No. 12. Р. 131–136 (in Russian).
4. Amano Y., Kitamura M., Takanо H. et al. Cardiac MR Imaging of Hypertrophic Cardiomyopathy: techniques, findings, and clinical relevance. Magn. Reson. Med. Sci. 2018. Published Online: January 18. 2018. DOI: 10.2463/mrms.rev.2017- 0145.
5. Elliott P., Anastasakis A., Borger M. et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task force for the diagnosis and мanagement of hypertrophic cardiomyopathy of the european society of cardiology (ESC). Eur. Heart. J. 2014. V. 39. P. 2733–79.